InMed Pharmaceuticals (OTCMKTS:IMLFF – Free Report) is one of 377 public companies in the “Biotechnology” industry, but how does it contrast to its peers? We will compare InMed Pharmaceuticals to similar companies based on the strength of its valuation, earnings, risk, dividends, institutional ownership, analyst recommendations and profitability. Earnings & Valuation This table compares InMed […]